What Devicare does

Devicare, S.L. is a privately held Spanish pharmaceutical company founded in 2011 and headquartered in Sant Cugat del Vallès, Barcelona. The company specializes in urinary health solutions, with its core portfolio centered on the Lit-Control® product line for kidney stone prevention and management. Its offering comprises patented and clinically proven dietary supplements (Lit-Control pH Balance for calcium oxalate stones at €39.99, pH Up for uric acid stones, and pH Down for infectious-origin stones), a Bluetooth-enabled Lit-Control pH Meter 2.0 (€199.99) for at-home urinary pH monitoring, calibration accessories (pH Buffer, pH Sensor), and the myLit-Control mobile application that syncs with the meter to track water intake, pH levels, and supplement consumption. Adjacent product lines address urinary infections (Metiofitina®, Citrafitina®, Utipro® Plus AF), intimate hygiene (Urogelus®, Nodorin®), urinary catheter care (Canoxidin®), and osteoporosis (Savebone®), with an additional offering of online consultations (nutritionist, stomatherapy, 24-hour urinalysis interpretation, and kidney stone analysis at €49.99-€199.99).

Devicare operates a direct-to-consumer e-commerce business model, selling through localized storefronts serving Spain, Italy, France, Turkey, and Hungary, with free shipping above €50 and subscription options offering 5% discounts. The go-to-market is augmented by a B2B2C layer through urologists, family doctors, nurses, and pharmacists who recommend Devicare products, supported by dedicated professional and distributor portals. The company holds Spanish pharmaceutical authorization (6646-PS) to sell non-prescription medical devices and operates in full GDPR compliance. In February 2026, Devicare completed its first international acquisition of U.S.-based IP6 International, Inc. (manufacturer of the IP6 Gold® nutritional brand), financed by a €1.2 million loan from COFIDES through the FONPYME fund, marking entry into the U.S. pharmaceutical and nutraceutical market. Cumulative equity funding of approximately $13 million has been raised across rounds from 2016-2021, with investors including EMESA Corporación Empresarial, Ship2B, Avançsa, Boyser, ELADIET, Ona Capital, Peroxfarma, and ICF Capital. The company has 11-50 employees and no disclosed revenue figure.

Name

Devicare

Legal name

DEVICARE, SL.

Website

https://devicare.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Devicare is a Spanish pharmaceutical company that sells patented dietary supplements, Bluetooth pH meters, and a companion mobile app (myLit-Control) for kidney stone prevention and broader urinary health, distributed via D2C e-commerce across Europe and the U.S.

Ownership category

akta.pro rank

Product category

Urology pharmaceuticals and urinary health products

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Surgical & Medical Instruments & Apparatus (3841), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Nephrology & Urology Pharmaceuticals (HLAIAAAM)

akta.pro secondary industries

Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)

Keywords

• Urinary health products
• Kidney stone supplements
• Urology medical devices
• Dietary supplements
• Telemedicine consultations

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Technology or R&D, Operations

Revenue model

1. Nutritional Supplement Sales: Sale of patented and clinically proven dietary supplements (Lit-Control pH Balance, pH Up, pH Down, Theobromine, Metiofitina, Citrafitina, Utipro Plus AF, Savebone) for urinary health, kidney stones, osteoporosis, and urinary infections. Products are sold directly to consumers through the e-commerce website with prices ranging from €9.99 to €54.99.
2. Medical Device Sales: Sale of medical devices including the Lit-Control pH Meter 2.0 (€199.99), Lit-Control pH Sensor (€99.99), Canoxidin for urinary catheters (€54.99), and pH Buffer solution (€9.99). These are non-prescription medical devices sold directly to consumers.
3. Online Consultation Services: Professional consultation services including nutritionist consultation (€49.99), stomatherapy consultation, 24-hour urinalysis interpretation consultation, and kidney stone analysis. These services involve collaboration with healthcare professionals and clinical analysis laboratories.
4. Intimate Hygiene Products: Sale of intimate hygiene products including Urogelus (€18.99) and Nodorin for managing odors due to unintentional leakages.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Devicare develops, brands and sells patented dietary supplements, medical devices and a companion mobile application focused on urinary health, primarily for the prevention, treatment and monitoring of kidney stones, urinary infections, intimate hygiene, urinary catheter care and osteoporosis. Its products are sold direct-to-consumer through its own multi-country e-commerce website with subscription options, paid online clinical consultations, and a dedicated portal for healthcare professional recommendations.

Product overview

Devicare is a Spanish pharmaceutical company offering a comprehensive portfolio of products and services focused on urinary health. The core offering centers on the Lit-Control® product line, which includes pH measurement devices (Lit-Control® pH Meter 2.0 with Bluetooth-enabled app sync), calibration accessories (pH Buffer, pH Sensor), and three clinically-proven dietary supplements (pH Balance for calcium oxalate stones, pH Up for uric acid stones, and pH Down for infectious stones). Supporting the device ecosystem is the myLit-control® App, which enables patients to monitor water intake, urinary pH, and supplement consumption with smart notifications. Beyond kidney stones, Devicare addresses adjacent conditions through intimate hygiene products (Urogelus®, Nodorin®), urinary infection treatments (Metiofitina®, Citrafitina®, Utipro® Plus AF), catheter care (Canoxidin®), and osteoporosis management (Savebone®). The portfolio also includes pure ingredient supplements (Theobromine) and online consultation services (nutritionist, stomatherapy, 24h urinalysis interpretation, kidney stone analysis). Recent international expansion through acquisition of U.S.-based IP6 International brings the IP6 Gold® brand into the portfolio.

Differentiator

Problem solved

Functional benefit

Brands

• Lit-Control®: Product line for kidney stone management including pH Balance, pH Up, pH Down, pH Meter 2.0, pH Buffer, and pH Sensor
• myLit-control® App
• Urogelus®
• Nodorin®
• Metiofitina®
• Citrafitina®
• Utipro® Plus AF
• Canoxidin®
• Savebone®

Products and services

• Lit-Control pH Balance Patented and clinically proven dietary supplement priced at €39.99 designed to reduce formation of calcium oxalate kidney stones and facilitate expulsion of residual fragments post-surgery; gluten-free, dairy-free, vegan, sugar-free and low-salt formulation for adult stone formers.
• Lit-Control pH Up Patented and clinically proven food supplement priced at €39.99 indicated for patients with uric acid kidney stones, supporting urinary alkalinization.
• Lit-Control pH Down Patented and clinically proven food supplement priced at €39.99 indicated for patients with kidney stones of infectious origin, supporting urinary acidification.
• Lit-Control pH Meter 2.0 Bluetooth-enabled urinary pH measurement device priced at €199.99 designed for kidney stone patients to monitor and track urinary pH levels for stone prevention, with synchronization to the myLit-control mobile app.
• Lit-Control pH Buffer Buffer solution priced at €9.99 used to calibrate and maintain the accuracy of the Lit-Control pH Meter 2.0 device.
• Lit-Control pH Sensor Replacement urinary pH sensor priced at €99.99 for use with the Lit-Control pH Meter device.
• myLit-control App Mobile application for kidney stone patients that monitors daily water intake, urinary pH and dietary supplement intake, provides educational content and smart notifications, and synchronizes via Bluetooth with the Lit-Control pH Meter 2.0; available on Google Play and Apple App Store.
• Urogelus Intimate hygiene product priced at €18.99 designed to avoid unpleasant odors from unintentional leakages and to eliminate infections and dermatitis.
• Nodorin Intimate hygiene product priced at €18.99 for managing odors from unintentional leakages.
• Metiofitina Product priced at €19.99 for the treatment of urinary infections.
• Citrafitina Product priced at €19.99 for the treatment of urinary infections.
• Utipro Plus AF Product priced at €29.99 for the treatment of urinary infections.
• Canoxidin Product priced at €54.99 for the care and management of urinary catheters.
• Savebone Product priced at €24.99 for osteoporosis treatment and bone health management.
• Theobromine Pure theobromine food supplement priced at €24.99, low in sugar, designed for patients who want to prevent or dissolve uric acid kidney stones.
• Nutritionist consultation Online consultation service priced at €49.99 with a clinical nutrition specialist for personalized dietary guidance related to urinary health.
• Stomatherapy consultation Online consultation priced at €49.99 with a stomatherapy nurse for specialized care guidance.
• 24h urinalysis interpretation consultation Online interpretation service priced at €49.99 for 24-hour urinalysis results, with professional analysis and guidance.
• 24h urinalysis interpretation consultation and report Comprehensive 24-hour urinalysis interpretation service priced at €99.99, including a detailed written report.
• Kidney stone analysis

Quantifiable outcome

• Patient testimonials report no renal colic episodes for 5+ years with regular Lit-Control use
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Laboratory for Renal Lithiasis Research (LILR) - University of the Balearic IslandscoreStrategic or Co-development PartnerDevicare partners with the LILR of the University of the Balearic Islands for pathological anatomy services related to kidney stone analysis. Samples are sent to the laboratory for analysis, and the laboratory uses information both for sample analysis (under Devicare's responsibility) and for scientific research.
• IP6 International, Inc.coreStrategic or Co-development PartnerU.S.-based manufacturer of IP6 Gold nutritional products, acquired by Devicare in February 2026. This acquisition marks Devicare's first international expansion and entry into the U.S. market, combining IP6 International's brand and commercial platform with Devicare's scientific expertise in IP6.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mission Pharmacal: US-based specialty pharmaceutical company with a dedicated urology portfolio including kidney-stone management and urinary-health products. Closely comparable to Devicare in therapeutic focus and physician-recommended D2C/promotional model.
• Amerilab Technologies: Manufacturer of effervescent and specialty dietary supplements, including urinary-health and pH-balancing products. Comparable to Devicare in the specialty-condition supplement manufacturing and brand-build model.
• Thorne: Premium DTC dietary-supplement brand with practitioner-channel and consumer e-commerce distribution. Comparable in DTC supplement positioning, scientific credibility emphasis and subscription model.
• Pure Encapsulations: Practitioner-grade supplement brand sold via healthcare professionals and direct channels. Comparable in clinically oriented, condition-targeted supplement positioning serving urinary and metabolic health segments.

Broad incumbents

• Coloplast: Global leader in ostomy, continence and wound-care products, including catheter care. Comparable to Devicare's Canoxidin® catheter-care line, though operating at vastly larger scale across multiple geographies.
• ConvaTec: Global medical-products company with an ostomy and continence-care franchise. Comparable in catheter and continence product categories addressed by Devicare's catheter-care line.
• Boston Scientific: Large-cap medical-device company with a significant urology and pelvic-health franchise. Comparable as a urology-focused device-and-therapy operator, though addressing surgical/procedural rather than home-monitoring use cases.

Emerging players

• STORZ Medical: Specialty manufacturer of shock-wave and urology devices including lithotripsy systems for kidney stones. Comparable in the kidney-stone treatment space, with overlap on hardware used in stone management.
• RenalGuard Solutions: Specialty medtech focused on preventing acute kidney injury and contrast-induced nephropathy. Adjacent but comparable as a kidney-focused specialty medical company targeting nephrology/urology patients.
• Life Extension: Long-standing DTC dietary-supplement brand with condition-targeted formulations and a strong e-commerce subscription model. Comparable in DTC supplement distribution and clinical-positioning strategy.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/devicare

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds7 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Devicare